IgM levels in plasma predict outcome in severe pandemic influenza

Journal of Clinical Virology

Volumn 58, Issue 3, 2013, Pages 564-567

  Justel, Mar ^a   Socias, Lorenzo ^b   Almansa, Raquel ^a   Ramírez, Paula ^c   Gallegos, Maria C ^b   Fernandez, Victoria ^b   Gordon, Monica ^c   Andaluz Ojeda, David ^a   Nogales, Leonor ^a   Rojo, Silvia ^a   Vallés, Jordi ^d   Estella, Angel ^e   Loza, Ana ^f   León, Cristobal ^f   Lopez Mestanza, Cristina ^a   Blanco, Jesús ^g   Berezo, Jose Ángel ^g   Rosich, Sara ^h   Cillòniz, Catia ⁱ   Torres, Antoni ⁱ   de Lejarazu, Raul Ortiz ^a   Martin Loeches, Ignacio ^d   Bermejo Martin, Jesus F ^a   more..

^a HOSPITAL CLÍNICO UNIVERSITARIO DE VALLADOLID   (Spain)

^b HOSPITAL SON LLÀTZER   (Spain)

^c HOSPITAL UNIVERSITARIO LA FE   (Spain)

^d HOSPITAL DE SABADELL   (Spain)

^e HOSPITAL DE JEREZ   (Spain)

^f HOSPITAL UNIVERSITARIO DE VALME   (Spain)

^g HOSPITAL UNIVERSITARIO RÍO HORTEGA   (Spain)

^h HOSPITAL UNIVERSITARI JOAN XXIII   (Spain)

ⁱ INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

Author keywords

Critical; Cytokines; Immunoglobulins; Influenza; Prognosis

Indexed keywords

ANTINEOPLASTIC AGENT; GAMMA INTERFERON; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN A; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; IMMUNOGLOBULIN G3; IMMUNOGLOBULIN G4; IMMUNOGLOBULIN M; INTERLEUKIN 10; INTERLEUKIN 12P70; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 7; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; STEROID; TUMOR NECROSIS FACTOR ALPHA;

ADULT; APACHE; ARTICLE; AUTOIMMUNE DISEASE; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; COMMUNITY ACQUIRED PNEUMONIA; CONTROLLED STUDY; CRITICALLY ILL PATIENT; DEATH; DISEASE ASSOCIATION; FEMALE; HEMATOLOGIC MALIGNANCY; HOSPITAL ADMISSION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOSUPPRESSIVE TREATMENT; INFLUENZA A (H1N1); INTENSIVE CARE UNIT; LUNG CANCER; MALE; MORTALITY; OUTCOME ASSESSMENT; PANDEMIC INFLUENZA; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; STEROID THERAPY;

CAP; CHRONIC OBSTRUCTIVE PULMONARY DISEASE; COMMUNITY ACQUIRED PNEUMONIA; COPD; CRITICAL; CYTOKINES; HBP; HIGH BLOOD PRESSURE; ICU; IMMUNOGLOBULINS; INFLUENZA; INTENSIVE CARE UNIT; PROGNOSIS;

ADULT; AGED; ANTIBODIES, VIRAL; COMMUNITY-ACQUIRED INFECTIONS; CRITICAL ILLNESS; FEMALE; HUMANS; IMMUNOGLOBULIN M; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; MALE; MIDDLE AGED; PLASMA; PNEUMONIA; PROGNOSIS; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84886284120     PISSN: 13866532     EISSN: 18735967     Source Type: Journal    
DOI: 10.1016/j.jcv.2013.09.006     Document Type: Article

References (11)

1. Gordon C.L., Johnson P.D.R., Permezel M., Holmes N.E., Gutteridge G., McDonald C.F., et al. Association between severe pandemic 2009 influenza A (H1N1) virus infection and immunoglobulin G(2) subclass deficiency. Clin Infect Dis 2010, 50(marzo (5)):672-678.
2. Chan J.F.-W., To K.K.-W., Tse H., Lau C.C.-Y., Li I.W.-S., Hung I.F.-N., et al. The lower serum immunoglobulin G2 level in severe cases than in mild cases of pandemic H1N1 2009 influenza is associated with cytokine dysregulation. Clin Vaccine Immunol 2011, 18(febrero (2)):305-310.
3. Mandell L.A., Wunderink R.G., Anzueto A., Bartlett J.G., Campbell G.D., Dean N.C., et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 2007, 44(marzo (Suppl. 2)):S27-S72.
4. Joachimiak M.P., Weisman J.L., May B.C. JColorGrid: software for the visualization of biological measurements. BMC Bioinformatics 2006, 7:225.
5. Qiu C., Tian D., Wan Y., Zhang W., Qiu C., Zhu Z., et al. Early adaptive humoral immune responses and virus clearance in humans recently infected with pandemic 2009 H1N1 influenza virus. PLoS ONE 2011, 6(8):e22603.
6. Jayasekera J.P., Moseman E.A., Carroll M.C. Natural antibody and complement mediate neutralization of influenza virus in the absence of prior immunity. J Virol 2007, 81(abril (7)):3487-3494.
7. Binder C.J. Natural IgM antibodies against oxidation-specific epitopes. J Clin Immunol 2010, 30(mayo (Suppl. 1)):S56-S60.
8. Almansa R., Anton A., Ramirez P., Martin-Loeches I., Banner D., Pumarola T., et al. Direct association between pharyngeal viral secretion and host cytokine response in severe pandemic influenza. BMC Infect Dis 2011, 11:232.
9. De Jong M.D., Simmons C.P., Thanh T.T., Hien V.M., Smith G.J.D., Chau T.N.B., et al. Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nat Med 2006, 12(octubre (10)):1203-1207.
10. Zheng R., Qin X., Li Y., Yu X., Wang J., Tan M., et al. Imbalanced anti-H1N1 immunoglobulin subclasses and dysregulated cytokines in hospitalized pregnant women with 2009 H1N1 influenza and pneumonia in Shenyang, China. Hum Immunol 2012, 73(septiembre (9)):906-911.
11. Martin-Loeches I., Díaz E., Vidaur L., Torres A., Laborda C., Granada R., et al. Pandemic and post-pandemic influenza A (H1N1) infection in critically ill patients. Crit Care Lond Engl 2011, 15(6):R286.